-
China’s NHSA Concludes Pre-Negotiation Talks for National Reimbursement Drug List
•
According to the Economic Observer, an independent Chinese weekly newsletter, a series of discussions preceding the National Reimbursement Drug List (NRDL) price negotiation occurred from October 16 to 18. These pre-negotiation talks, which serve as one-on-one communications prior to the formal negotiation process, were divided into three groups this year.…
-
NHSA Updates NRDL Review, Adds Three Domestic Western Medicines
•
The National Healthcare Security Administration (NHSA) has issued a notification regarding the review and correction of results related to drugs on the preliminary formal review list of the National Reimbursement Drug List (NRDL). This update follows feedback collected from August 7 to 13, 2024. The revised list now includes 249…
